Fierce Pharma Asia—Enhertu’s HER2-low breast cancer win; Takeda’s $2B gene therapy pact; Xtandi march-in campaign aliu Fri, 02/25/2022 – 06:53 More: Fierce Pharma Asia—Enhertu's HER2-low breast cancer win; Takeda's B gene therapy pact; Xtandi march-in campaign Source: fierce
read moreFigures by National Audit Office estimate that programme prevented up to 262,000 hospitalisations More: Community pharmacies save 20,000 lives during initial vaccination phases Source: News
read moreEli Lilly, Boehringer Ingelheim’s Jardiance clinches heart failure edge with FDA nod for wider label fkansteiner Thu, 02/24/2022 – 14:11 More: Eli Lilly, Boehringer Ingelheim's Jardiance clinches heart failure edge with FDA nod for wider label Source: fierce
read moreTeva, Endo and more back on the hook in San Francisco opioid trial fkansteiner Thu, 02/24/2022 – 11:23 More: Teva, Endo and more back on the hook in San Francisco opioid trial Source: fierce
read moreMerck KGaA pledges $550M in manufacturing upgrades after closing buyout of mRNA CDMO Exelead kdunleavy Thu, 02/24/2022 – 11:20 More: Merck KGaA pledges 0M in manufacturing upgrades after closing buyout of mRNA CDMO Exelead Source: fierce
read moreGlaxoSmithKline, Medicago’s plant-based COVID vaccine, Covifenz, wins first approval aliu Thu, 02/24/2022 – 11:17 More: GlaxoSmithKline, Medicago’s plant-based COVID vaccine, Covifenz, wins first approval Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals